Suny Downstate Medical Center
Brooklyn, New York 12201-0009
2 studies enrolling now · 156 studies all time
What they study most
Acne Vulgaris, Acute Chest Syndrome, Acute Coronary Syndrome, Acute Myocardial Infarction (AMI), Advanced, Persistent, or Recurrent Endometrial Cancer, Aging, Allergic Rhinitis, Anal Cancer, Angiotensin Converting Enzyme Inhibitor Induced Angioedema, Antiretroviral Toxicity, Arthritis, Rheumatoid, Asthma
Studies at this site
- A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo — Recruiting now
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis — Running, not enrolling
- A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer — Stopped early
- A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old — Completed
- 14022 ATTUNE Cementless RP Clinical Performance Evaluation — Running, not enrolling
- Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C — Enrolling by invitation
- Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years — Running, not enrolling
- 4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs — Running, not enrolling
- Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial — Completed
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer — Completed
- Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1) — Completed
- Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo — Completed
- Risk Factors for Endometrial Cancer in Black Women — Running, not enrolling
- A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA) — Completed
- EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
- Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women — Completed
- A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus — Completed
- Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer — Completed
- Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis — Completed
- 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants — Completed
- Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension — Completed
- Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain — Completed
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor — Completed
- Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb — Stopped early
- Adjunctive Treatment for Chronic Rhinosinusitis With Nasal Polyposis — Status unconfirmed
- Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma — Completed
- Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry — Status unconfirmed
- Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation — Completed
- Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3) — Stopped early
- Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections — Completed
- A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia — Completed
- Trial on Endovascular Aneurysm Management — Stopped early
- Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy — Completed
- A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia — Completed
- Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa — Stopped early
- Dapagliflozin in Respiratory Failure in Patients With COVID-19 — Completed
- An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer — Stopped early
- Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention — Completed
- Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance — Completed
- Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants — Running, not enrolling
- Barbershop Talk: HIV Prevention for African American Heterosexual Men — Completed
- Convalescent Plasma in Outpatients With COVID-19 — Completed
- Assessment of Suppression of Cutaneous Allergic Responses and Pruritus by Topical Doxycycline — Status unconfirmed
- Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline — Status unconfirmed
- Mild and Rapidly Improving Stroke Study — Completed
- Established Status Epilepticus Treatment Trial — Completed
- Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema — Completed
- Combination of Preoperative Gabapentin and TAP Blocks in Decreasing Postoperative Pain — Withdrawn before enrolling
- ASPREE Cancer Endpoints Study — Status unconfirmed